Wednesday, November 13

Healthcare

LivaNova rises following possible CMS reimbursement boost for vagus nerve stimulation

08/29/20241 Min Read

boost CMS LivaNova nerve reimbursement rises stimulation vagus

Previous ArticlePalatin stock climbs 8% on Phase 3 testing update for PL9643

Next Article Marijuana rescheduling unlikely to lead to cannabis banking reform